Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) EBITDA Margin % : 0.00% (As of Apr. 2023)

Advanced Proteome Therapeutics EBITDA Margin % Chart

Advanced Proteome Therapeutics Annual Data
	Trend	Jul13	Jul14	Jul15	Jul16	Jul17	Jul18	Jul19	Jul20	Jul21	Jul22
EBITDA Margin %		Get a 7-Day Free Trial					-	-	-	-	-

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Advanced Proteome Therapeutics's EBITDA Margin %

For the Biotechnology subindustry, Advanced Proteome Therapeutics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's EBITDA Margin % falls into.

Advanced Proteome Therapeutics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Advanced Proteome Therapeutics's EBITDA Margin % for the fiscal year that ended in Jul. 2022 is calculated as

Advanced Proteome Therapeutics's EBITDA Margin % for the quarter that ended in Apr. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics  (OTCPK:APTCF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Advanced Proteome Therapeutics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description